NVCT

Nuvectis Pharma, Inc.

—

$19.45

+6.14% today

2 insiders bought $1.17M ·

Price

hover · 4 moves explained

11 buys9 8-K

Insider signal47/ 100Low

Why it's flagged

BENTSUR RON — Chairman & CEOC-suite buy$916K buyLarge buy$1.2M netNet buying 90d

AI BriefPro

Short % float

Pro

Days to cover

Pro

Analyst consensus

Strong Buy

$29.20target+50.1%vs $19.45 today

$20.00 low today target$39.00 high

5 analysts · ~12-month consensus · as of Jul 1. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 1 of last 4

Earnings per share · actual vs forecast

Q2 '25-19.2%

−$0.30

exp −$0.25

Q3 '25-76.0%

−$0.44

exp −$0.25

Q4 '25-0.6%

−$0.31

exp −$0.31

Q1 '26+17.2%

−$0.26

exp −$0.31

Type	Date	Insider	Title	Shares	Price	Value
Buy	2026-07-01	Mosseri Marlio Charles	—	50,000	$18.32	$916.0K
Buy	2026-07-01	BENTSUR RON	Chairman & CEO	12,500	$20.00	$250.0K
Grant	2026-01-09	BENTSUR RON	Chairman & CEO	150,000	—	—
Grant	2026-01-09	Carson Michael J.	Vice President, Finance	61,200	—	—
Grant	2026-01-09	Poradosu Enrique	Chief Science & Business Off	150,000	—	—

Buy

Mosseri Marlio Charles

2026-07-01

$916.0K

50,000 @ $18.32

Buy

BENTSUR RON

Chairman & CEO · 2026-07-01

$250.0K

12,500 @ $20.00

Grant

BENTSUR RON

Chairman & CEO · 2026-01-09

—

150,000 shares

Grant

Carson Michael J.

Vice President, Finance · 2026-01-09

—

61,200 shares

Grant

Poradosu Enrique

Chief Science & Business Off · 2026-01-09

—

150,000 shares

14 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →